You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II squamous cell carcinoma of the hypopharynx

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous

Recruiting
  • Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
  • +50 more
  • transoral robotic surgery
  • quality of life assessment
  • Columbus, Ohio
    Ohio State University Medical Center
Oct 28, 2022

Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • +3 more
  • Eliminating RT to the elective neck
  • RT standard of care
  • Erlangen, Bavaria, Germany
    Universitätsklinikum Erlangen, Strahlenklinik
Sep 8, 2023

Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia

Active, not recruiting
  • Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
  • Nelfinavir (Viracept®) 1250 mg
  • FMISO
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 30, 2021

Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell

Completed
Has Results
  • Stage IV Squamous Cell Carcinoma of the Hypopharynx
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2021

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and

Recruiting
  • Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • +4 more
  • Cemiplimab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 17, 2023

Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • no intervention
  • Wuhan, Hubei, China
    Renmin hosptial of Wuhan University
Jul 29, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,

Recruiting
  • Head Neck Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health Sciences
Aug 8, 2022

Squamous Cell Carcinoma of the Oropharynx, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Oral Cavity

Active, not recruiting
Has Results
  • Squamous Cell Carcinoma of the Oropharynx
  • +7 more
  • Tampa, Florida
  • +2 more
Dec 30, 2022

Head and Neck Squamous Cell Carcinoma Trial in Dallas (Intensity modulated radiation therapy (IMRT))

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Intensity modulated radiation therapy (IMRT)
  • Dallas, Texas
    University of Texas Southwestern Medical Center - Dallas
Nov 18, 2022

Metastatic Penile Squamous Cell Carcinoma, Stage III Penile Cancer AJCC v8, Stage IV Penile Cancer AJCC v8 Trial in Phoenix,

Not yet recruiting
  • Metastatic Penile Squamous Cell Carcinoma
  • +3 more
  • Enfortumab Vedotin
  • Phoenix, Arizona
  • +2 more
Oct 23, 2023

Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive)

Recruiting
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +10 more
  • Intensity-Modulated Radiation Therapy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Stage T3 Squamous Cell Carcinomas of the Scalp

Active, not recruiting
  • Squamous Cell Carcinoma
  • +2 more
    • Maastricht, Netherlands
      Ellen Oyen
    Aug 3, 2023

    Head and Neck Squamous Cell Carcinoma, HNSCC, Squamous Cell Carcinoma of the Larynx Trial (Cemiplimab-Rwlc)

    Withdrawn
    • Head and Neck Squamous Cell Carcinoma
    • +4 more
    • (no location specified)
    Aug 1, 2022

    Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

    Not yet recruiting
    • Advanced Esophageal Squamous Carcinoma With Oligometastases
    • simultaneous with radiotherapy
    • synchronous with radiotherapy
    • (no location specified)
    Nov 16, 2023

    Oropharynx Squamous Cell Carcinoma, Larynx Squamous Cell Carcinoma, Hypopharynx Squamous Cell Carcinoma Trial in Brussels

    Recruiting
    • Oropharynx Squamous Cell Carcinoma
    • +3 more
    • IO102
    • IO103
    • Brussels, Belgium
      Cliniques Universitaires Saint-Luc
    May 6, 2022

    Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Skin
    • Carrilizumab with albumin-binding paclitaxel
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    May 23, 2023

    Oral Squamous Cell Carcinoma Trial in Beijing (Toripalimab)

    Not yet recruiting
    • Oral Squamous Cell Carcinoma
    • Beijing, China
      Peking Union Medical College Hospital, Chinese Academy of Medica
    Apr 5, 2023

    Lung Squamous Cell Carcinoma Trial in Yancheng (To explore the efficacy and safety of immune checkpoint inhibitor combined with

    Recruiting
    • Lung Squamous Cell Carcinoma
    • To explore the efficacy and safety of immune checkpoint inhibitor combined with endostar and chemotherapy in the treatment of advanced lung squamous cell carcinoma (stage IIIB-IV).
    • Yancheng, Jiangsu, China
      Yancheng Clinical College of Xuzhou Medical University
    Mar 21, 2023

    Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

    Completed
    Has Results
    • Caregiver
    • +37 more
    • Communication Intervention
    • +5 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Dec 14, 2022

    Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

    Recruiting
    • Metastatic Esophageal Squamous Cell Carcinoma
    • Intensity-modulated radiotherapy concurrent with capecitabine
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer center
    Aug 21, 2022

    Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • Guangzhou, Guangdong, China
    • +4 more
    Nov 16, 2023